As a result of the FDA PAT initiative an increased interest in process understanding is seen in the pharmaceutical industry. Also a rising interest in “consistent” processes is noticed. Aim is that during pharmaceutical processing each particle should undergo the same experience independent of equipment or scale of operation. This paper reviews the consequences of transferring a fluid bed process from scale 1 to a larger scale 2.
<--- Link to PDF file